Feng Zhang

Dr. Feng Zhang is a molecular biologist and researcher at the Broad Institute of MIT and Harvard, where he serves as an associate professor. His research focuses on the development and application of gene editing technologies, with particular emphasis on CRISPR-based systems. Zhang’s work has contributed significantly to understanding how molecular tools can be engineered for therapeutic applications.

CRISPR and Gene Editing

Zhang’s laboratory has investigated the natural diversity and evolution of CRISPR systems found across different bacterial species. This foundational work has informed the development of new gene editing approaches and variants of CRISPR tools with expanded capabilities. His research has helped establish methods for applying these systems to address genetic diseases and other biomedical challenges.

Recognition and Impact

Zhang’s contributions to gene editing have been recognized through various scientific awards and publications in leading journals. His work has helped advance the field of precision medicine by improving both the specificity and versatility of molecular editing tools available to researchers and clinicians.